Kiromic BioPharma, Inc. , an artificial intelligence driven allogeneic cell therapy company, engages in developing the multi-indication allogeneic T cell therapies that exploits the natural potency of the Gamma Delta T cell to target solid tumors.
Kiromic Biopharma stock last closed at $4.39, up 3.78% from the previous day, and has decreased 82.15% in one year. It has underperformed other stocks in the Biotechnology industry by 0.59 percentage points. Kiromic Biopharma stock is currently +18.33% from its 52-week low of $3.71, and -83.79% from its 52-week high of $27.09.
There are currently 608,218 KRBP shares outstanding. The market capitalization of KRBP is $2.67M. In the last 24 hours, 290,556 KRBP shares were traded.
You will need a brokerage account in order to access the NASDAQ market and buy KRBP stock.
In our opinion, eToro is the best brokerage. Here's why:
Get $10 towards your purchase of stock by opening an account with eToro now.Open eToro Account
Now that you've picked your brokerage, you need to fill out some personal information so you are able to buy KRBP stock today.
Now that you've created your account on the best app for stock investing, your next step is to transfer the money for your investment:
Watch the walkthrough below for more details depositing money into your new brokerage account.
Once you have chosen the best place to buy Kiromic Biopharma stock, it's important to research their stock before you invest, so you truly comprehend the risk and upside.
WallStreetZen was built to help part-time investors perform more in-depth fundamental analysis in minutes instead of hours.
You can see all of the due diligence checks on KRBP's stock page.
Analysts use many financial metrics, analyses, models, and charts to gauge KRBP's fair value.
Using relative valuations metrics:
You can do additional valuation analysis on KRBP's stock here.
You can dig deeper into what analysts are projecting on the Kiromic Biopharma stock forecast page.
Over the last 12 months, executives and large shareholders at KRBP have not bought or sold any shares.
Research more about who owns KRBP stock here.
No, Kiromic Biopharma doesn't provide an income stream by paying out dividends.
One of the major reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to find out what other community members have to say.
There are two main options:
Hit the Open button and your broker will place your order.
If you require additional help buying stocks on eToro, watch the how to video below:
Now that you own some KRBP shares, you'll want to keep up with your investment.
Make a watchlist to keep track of your KRBP stock.
To summarize, here are the 6 steps for buying Kiromic Biopharma stock:
If you require a brokerage account, eToro is our recommended venue.Get Started with eToro Today
If you want to keep an eye on your new investment in Kiromic Biopharma, click below.
How much does it cost to buy one Kiromic Biopharma share?
What is the best way to buy Kiromic Biopharma stock?